Risk of Type 2 Diabetes among US - Foreign Born Non-Hispanic Asians: Evidence from NHANES 2011-12
Journal Title: Journal of Diabetes and Obesity - Year 2015, Vol 2, Issue 1
Abstract
Aims/Introduction: The purpose of this study was to compare risks for metabolic dysfunction and type 2diabetes among Non-Hispanic Asian and Non-Hispanic white adults using new nationally representative data in the U.S. We compared the metabolic profiles of U.S.-born vs. foreign –born Non-Hispanic Asian adults. Materials and Methods: This study used NHANES 2011-2012 adult data for Non-Hispanic Asians (n=827) and Non-Hispanic Whites (n=2,108). Standardized risk threshold cutoffs for blood pressure, lipids, and glucose were used to determine metabolic dysfunction. Logistic regression models were used to estimate odds of metabolic dysfunction. Covariates included age, sex, education level, marital status, BMI, serum cotinine exposure (for smoking), and nativity. Results: Compared to Non-Hispanic Whites, Non-Hispanic Asians were at increased risk for HDL≤40 mg/dL (men) and≤50 mg/dL (women) (OR=1.78, 95% CI=1.02-3.11), HbA1c≥ 5.6 % (OR=3.23, 95% CI= 1.79-5.90), and HbA1c≥6.5 % (OR=3.32, 95% CI=1.58-6.98). Relative to U.S.-born Non-Hispanic Asians, foreign- born Non-Hispanic Asians had elevated risk for HbA1c ≥ 6.5 % (OR=1.94, 95% CI=1.24-3.02), total cholesterol ≥ 200 mg/dL (OR= 1.77, 95 %CI = 1.31- 2.39) and LDL ≥ 100 mg/dL (OR=1.79, 95% CI=1.23-2.59). Conclusions: This is the first analysis of metabolic dysfunction and type 2 diabetes between U.S vs foreign-born Non-Hispanic Asians using nationally representative data. Non-Hispanic Asian immigrants appear to be the most at risk. Independent of BMI, Non-Hispanic Asians were at significantly higher risk for low HDL and type 2 diabetes compared to Non-Hispanic white adults.
Authors and Affiliations
Hannah L. Jackson
Keywords
Related Articles
- EP ID EP417822
- DOI 10.15436/2376-0494.15.015
- Views 81
- Downloads 0
Vagal Nerve Block for Improvements in Glycemic Control in Obese Patients with Type 2 Diabetes Mellitus: Three-Year Results of the VBLOC DM2 Study
Background: The VBLOC DM2 study demonstrated that intermittent electrical vagal blocking (vBloc therapy) was safe among subjects with obesity and type 2 diabetes mellitus (DM2) and led to clinically meaningful improvemen...
Correlation of leptinemia with components of metabolic syndrome in youths: influence of obesity, gender and stage of puberty
Objective: To evaluate correlation of leptinemia with components of Metabolic Syndrome (MetS) in Moroccan youths, and effect of obesity, Blood Pressure (BP), gender and puberty stage on MetS-components. Study design: Ant...
Addition of Metformin to Liraglutide, A GLP-1 Receptor Agonist, Improves Glycemic Control in Patients with Type 2 Diabetes Mellitus
Background: The maximum permissible dose of liraglutide, a GLP-1 receptor agonist, under the Japanese Heath Insurance system is 0.9 mg/day. We determined the effects of adding metformin to liraglutide therapy in Japanese...
Possibility of Diabetes Prevention by High-amylose Rice and Super Hard Rice
Diabetes is one of the most devastating diseases in the world Its prevention is very important in addition to the development of the curing technology We started the cooperative research on low Glycemic Index GI rice...
Occurrence of Left Ventricular Hypertrophy in Subjects with Metabolic Syndrome: Role of Adiponectin
This study was designed to evaluate the role of total plasma adiponectin ADPN on the occurrence of left ventricular hypertrophy in subjects with metabolic syndrome MetS compared to a control group without MetS The m...